Erythroleukemia: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 16: Line 16:


{{SK}} Acute erythroid leukemia; acute Di Guglielmo syndrome; erythroleukemia  
{{SK}} Acute erythroid leukemia; acute Di Guglielmo syndrome; erythroleukemia  
==Overview==
==[[Erythroleukemia overview|Overview]]==
==[[Erythroleukemia classification|Classification]]==
 
==[[Erythroleukemia pathophysiology|Pathophysiology]]==
 
==[[Erythroleukemia causes|Causes]]==
 
==[[Erythroleukemia differential diagnosis|Differentiating Erythroleukemia from other Diseases]]==
 
==[[Erythroleukemia epidemiology and demographics|Epidemiology and Demographics]]==
 
==[[Erythroleukemia natural history, complications and prognosis|Natural History, Complications and Prognosis]]==
 
 
'''Erythroleukemia''' (or "acute Di Guglielmo syndrome") is a rare form of [[acute myeloid leukemia]] where the [[myeloproliferation]] is of [[erythrocyte]] precursors.
'''Erythroleukemia''' (or "acute Di Guglielmo syndrome") is a rare form of [[acute myeloid leukemia]] where the [[myeloproliferation]] is of [[erythrocyte]] precursors.



Revision as of 20:33, 12 September 2012

Template:DiseaseDisorder infobox Template:Erythroleukemia Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Synonyms and keywords: Acute erythroid leukemia; acute Di Guglielmo syndrome; erythroleukemia

Overview

Classification

Pathophysiology

Causes

Differentiating Erythroleukemia from other Diseases

Epidemiology and Demographics

Natural History, Complications and Prognosis

Erythroleukemia (or "acute Di Guglielmo syndrome") is a rare form of acute myeloid leukemia where the myeloproliferation is of erythrocyte precursors.

It is defined at type "M6" under the FAB classification.[1]

Types

It can be classified as follows:

  • M6a; Erythroid/Myeloid
  • M6b; Pure Erythroid Malignancy

Criteria for diagnosis of M6

M6a

50% or more of all nucleated bone marrow cells are erythroblasts, Dyserythropoiesis is prominent and 30% or more of the remaining cells (non- erythroid) are myeloblasts.

M6b ( Pure Erythroid Malignancy )

In rare cases the erythroid lineage is the only obvious components of an acute leukemia; a myeloblast component is not apparent. The erythroid component consists predominantly or exclusively of proerythroblasts and early basophilic erythroblasts. These cells may constitute 90% or more of the marrow elements. Despite this lack of myeloblast, these cases should be considered acute leukemias. In WHO proposal the blastic leukeimas that are limited to the erythroid series are designated pure erythroid malignancy.

Related chapters

Resources

References

Kowal-Vern A, Mazzella FM, Cotelingam JD, Shrit MA, Rector JT, Schumacher HR (2000). "Diagnosis and characterization of acute erythroleukemia subsets by determining the percentages of myeloblasts and proerythroblasts in 69 cases". Am. J. Hematol. 65 (1): 5–13. PMID 10936857.


Template:WikiDoc Sources